How to Maximize Success Using the LeeLu Launch Panel In the high-stakes world of diagnostic development, the transition from a laboratory concept to a market-ready product is often fraught with technical hurdles and regulatory delays. The LeeLu Fluorescent Lateral Flow Reader, often referred to as the “Launch Panel” or research platform, is a high-sensitivity instrument designed specifically to bridge this gap. By providing a standardized, highly flexible R&D environment, it allows partners to iterate rapidly and maintain continuity throughout the product lifecycle.
To maximize your success with this platform, you must leverage its capabilities across four critical stages: Feasibility, Optimization, Validation, and Scalability. 1. Accelerate Early Feasibility
Success begins by utilizing the LeeLu Reader as an off-the-shelf tool to validate assay feasibility from day one.
Establish Baseline Sensitivity: Use the reader’s best-in-class optical sensitivity to detect low-abundance biomarkers, such as Europium and QDOT particles, which are often missed by visual inspection.
Multiplex Early: Don’t wait for later stages to test multiple biomarkers. The LeeLu is designed to read multiple biomarkers on a single sample strip, allowing you to build more complex diagnostic panels from the start. 2. Optimize with Time-Lapse Data
One of the most powerful features of the LeeLu software is its time-lapse measurement functionality.
Analyze Kinetic Profiles: Instead of just a single “end-point” reading, use time-lapse data to understand the flow dynamics and reaction kinetics of your assay. This helps in identifying the optimal read time and reducing development time through faster iteration.
Refine Algorithms: Use the raw data exported from the LeeLu to generate assay-specific algorithms that can eventually be transferred to handheld or disposable readers. 3. Ensure Continuity in Validation
A common pitfall in diagnostic launches is “reader drift,” where results from R&D don’t match the final commercial device.
Standardize Configurations: The LeeLu allows you to utilize the same optical configuration during development as your final intended product, significantly reducing regulatory risk.
Focus on Repeatability: Leverage the high repeatability between readers to ensure that your quality control (QC) processes are robust enough for manufacturing. 4. Strategic Launch Positioning
Maximizing success isn’t just about the hardware; it’s about the Go-To-Market (GTM) strategy enabled by the hardware.
Highlight Quantitative Data: In a market moving toward point-of-care (POC) precision, market your test as “quantitative” rather than just “positive/negative.” The LeeLu removes the unreliability of the human eye, which is a major selling point for clinicians.
Leverage Distribution Partners: For rapid US market entry, consider collaborating with established distributors like Attogene, who already integrate the LeeLu into their ecosystem.
By treating the LeeLu Launch Panel not just as a laboratory tool but as a complete development-to-deployment platform, you can slash time-to-market and ensure your diagnostic product meets the highest standards of clinical accuracy.
The technical steps for transferring algorithms to handheld devices? Current pricing and distribution options in your region?
Product launch guide: Steps, stages & checklist for teams – Asana
Leave a Reply